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RAGE against tumors
Inflammation plays an important role in tumor development. 
Using a chemically induced (DMBA/TPA) skin carcinogen-
esis mouse model, Gebhardt and colleagues implicated the 
receptor for advanced glycation end products (RAGE) in 
tumor progression. In mice lacking RAGE—a member of the 
immunoglobulin superfamily that has previously been impli-
cated in inflammatory disorders—tumors developed at later 
time points, were smaller, occurred less frequently, and exhib-
ited less proliferation than in the wild-type control animals. In 
addition, the dermal inflammatory infiltration was dampened 
in these tumors. Lack of a significant induction of expression 
of candidate proinflammatory molecules and a concomitant 
upregulation of the RAGE ligands S100a8 and S100a9 further 
supported a role for RAGE in inflammation and tumorigenesis. 
RAGE expression on immune cells but not on keratinocytes or 
endothelial cells was essential for inflammatory cell infiltration 
and epidermal hyperplasia. Thus, RAGE appears to be critical 
for maintaining an inflammatory microenvironment to promote 
epithelial tumor development. (J Exp Med 205:275–85, 2008)
By the feet of geckos
Mimicking the ability of geckos to adhere to vertical and 
inverted surfaces, Mahdavi and colleagues recently developed 
a tape-based tissue-compliant synthetic adhesive. The polymer 
poly(glycerol-co-sebacate acrylate) was modified according to 
the nanopatterned topography of the gecko foot to generate a 
biocompatible and biodegradable elastomer. Because other 
gecko-inspired adhesives have not been tested on biological 
tissues, in vitro examination of adhesion strength of this elas-
tomer to porcine intestinal tissue was conducted. Importantly, 
this adhesive covalently cross-linked with wet tissue, which 
makes it particularly promising as a suture/staple replacement 
following surgery; as a waterproof sealant for hollow-organ 
anastomoses; for mesh grafts to treat hernias, ulcers, and burns; 
and for hemostatic wound dressings. (Proc Natl Acad Sci USA 
105:2307–12, 2008)
Melanoma-specific drug target
A majority of melanomas have a kinase-activating mutation 
(V600E) in the B-Raf oncogene. Thus, therapeutic inhibition 
of this kinase is an ideal mechanism for treating these often 
chemoresistant tumors. Tsai and colleagues utilized a structure-
based small-molecule discovery approach to screen more than 
20,000 compounds in an effort to identify specific kinase inhib-
itors that selectively targeted the V600E B-Raf allele. Indeed, 
co-crystallization of candidate molecules with the kinase and 
subsequent biochemical analysis revealed that propane-1-sul-
fonic acid [3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbon-
yl)-2,4-difluorophenyl]amide (PLX4720) was selective for the 
B-Raf allele compared with a diverse panel of kinases. It also 
inhibited V600E B-Raf kinase activity in vitro at concentrations 
much lower than the wild-type allele. More importantly, this 
compound inhibited downstream kinase activity, decreased 
growth rates, and initiated an apoptotic response only in cell 
lines harboring the V600E mutation. In addition, in BRAFV600E 
tumor xenograft models, PLX4720 substantially blocked tumor 
growth. Thus, the small-molecule inhibitor selectively targets 
the activated mutant B-Raf in melanoma cell lines and subse-
quently blocks proliferation and causes tumor regression. This 
exciting discovery marks the first therapeutic molecule that 
selectively inhibits a target that occurs only in tumors. (Proc 
Natl Acad Sci USA 105:3041–6, 2008)
A colorful view of cell cycle transitions
Although understanding cell cycle progression has been the 
focus of much work, visualization of the transition from G1 to 
S has been difficult to achieve. Recently, Sakaue-Sawano and 
colleagues developed a method to do just that. Geminin and 
Cdt1, two proteins that oscillate during cell cycle phase transi-
tions, were fluorescently labeled and transduced via lentiviral 
vectors. Because Cdt1 levels, which were marked with red, 
peak in G1 and Geminin levels, which were marked with green 
and were highest in S/G2/M, melding of the two signals to pro-
duce a yellow color indicated the G1/S transition. Additionally, 
cell sorting of red, yellow, and green populations and subse-
quent analysis of cellular functions will be applicable to many 
biological questions. This fluorescent, ubiquitination-based 
cell cycle indicator (Fucci) was employed to monitor cell cycle 
dynamics during wound healing, progression of tumor cells in 
live mice, and development of neuronal tissue in Fucci trans-
genic mice. Thus, this dual-color imaging technique facilitates 
examination of cell cycle transitions via in vivo analysis of spa-
tial and temporal dynamics. (Cell 132:487–98, 2008)
Taking the temperature of ulceration
Lower-extremity complications in diabetic patients often 
involve sensory neuropathy. Identification of preulcerative 
inflammation in the feet may ultimately predict ulceration. 
Armstrong and colleagues conducted a physician-blinded, 18-
month, randomized controlled trial to evaluate the effective-
ness of self-administered infrared temperature-probe monitor-
ing to reduce the incidence of foot ulcers in high-risk diabetic 
veterans. Strikingly, patients who ulcerated reported a temper-
ature 4.8 times higher in the affected site on one foot than in 
the corresponding site on the other foot. Given that diabetic 
patients, their families, and even health-care professionals have 
difficulty identifying early warning signals for lower-extremity 
ulceration, these results strongly suggest that implementation 
of a simple temperature device strategy may be used to effec-
tively reduce foot ulceration. (Am J Med 120:1042–6, 2007)Journal of Investigative Dermatology (2008), 128, 1349. doi:10.1038/
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